Free Trial

Colgate-Palmolive (NYSE:CL) Shares Sold by Fiera Capital Corp

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)

Fiera Capital Corp trimmed its holdings in Colgate-Palmolive (NYSE:CL - Free Report) by 20.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,128,448 shares of the company's stock after selling 283,549 shares during the quarter. Fiera Capital Corp owned approximately 0.14% of Colgate-Palmolive worth $89,949,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Haverford Trust Co lifted its position in Colgate-Palmolive by 3.5% during the 4th quarter. Haverford Trust Co now owns 54,713 shares of the company's stock worth $4,361,000 after acquiring an additional 1,850 shares during the period. Sound View Wealth Advisors Group LLC lifted its holdings in shares of Colgate-Palmolive by 1.8% during the fourth quarter. Sound View Wealth Advisors Group LLC now owns 8,164 shares of the company's stock worth $651,000 after purchasing an additional 142 shares during the period. Beacon Pointe Advisors LLC grew its position in Colgate-Palmolive by 31.1% in the 4th quarter. Beacon Pointe Advisors LLC now owns 136,979 shares of the company's stock valued at $10,919,000 after buying an additional 32,529 shares during the last quarter. Apexium Financial LP acquired a new position in Colgate-Palmolive in the 4th quarter valued at $210,000. Finally, Lazard Freres Gestion S.A.S. raised its position in Colgate-Palmolive by 11.2% during the 4th quarter. Lazard Freres Gestion S.A.S. now owns 418,205 shares of the company's stock worth $31,472,000 after buying an additional 42,112 shares during the last quarter. Hedge funds and other institutional investors own 80.41% of the company's stock.

Analysts Set New Price Targets


CL has been the topic of a number of analyst reports. UBS Group lifted their price target on Colgate-Palmolive from $93.00 to $95.00 and gave the company a "buy" rating in a research note on Monday, January 29th. Evercore ISI upped their price target on shares of Colgate-Palmolive from $90.00 to $96.00 and gave the stock an "outperform" rating in a research note on Monday, April 8th. Royal Bank of Canada raised their price objective on shares of Colgate-Palmolive from $88.00 to $95.00 and gave the company a "sector perform" rating in a research note on Monday, April 29th. JPMorgan Chase & Co. upped their target price on shares of Colgate-Palmolive from $88.00 to $90.00 and gave the stock an "overweight" rating in a research report on Thursday, January 18th. Finally, Raymond James upgraded shares of Colgate-Palmolive from a "market perform" rating to an "outperform" rating and set a $91.00 price target for the company in a research report on Monday, January 29th. Three equities research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $92.35.

Check Out Our Latest Analysis on CL

Insider Activity

In other news, CEO Noel R. Wallace sold 69,948 shares of the firm's stock in a transaction dated Tuesday, February 20th. The stock was sold at an average price of $84.22, for a total transaction of $5,891,020.56. Following the completion of the sale, the chief executive officer now directly owns 286,881 shares in the company, valued at $24,161,117.82. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, CEO Noel R. Wallace sold 69,948 shares of Colgate-Palmolive stock in a transaction on Tuesday, February 20th. The shares were sold at an average price of $84.22, for a total value of $5,891,020.56. Following the completion of the sale, the chief executive officer now owns 286,881 shares in the company, valued at $24,161,117.82. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider John W. Kooyman sold 3,497 shares of the stock in a transaction on Tuesday, May 7th. The shares were sold at an average price of $93.47, for a total transaction of $326,864.59. Following the transaction, the insider now owns 3,181 shares in the company, valued at $297,328.07. The disclosure for this sale can be found here. Over the last three months, insiders sold 89,209 shares of company stock worth $7,667,425. 0.34% of the stock is currently owned by company insiders.

Colgate-Palmolive Trading Down 0.4 %

Shares of Colgate-Palmolive stock traded down $0.40 during trading hours on Friday, reaching $94.13. The stock had a trading volume of 4,135,150 shares, compared to its average volume of 4,610,579. The firm has a market capitalization of $77.23 billion, a price-to-earnings ratio of 29.79, a P/E/G ratio of 3.48 and a beta of 0.40. Colgate-Palmolive has a 1 year low of $67.62 and a 1 year high of $95.59. The company has a current ratio of 1.06, a quick ratio of 0.70 and a debt-to-equity ratio of 13.21. The firm has a 50 day simple moving average of $89.81 and a two-hundred day simple moving average of $83.70.

Colgate-Palmolive (NYSE:CL - Get Free Report) last released its quarterly earnings data on Friday, April 26th. The company reported $0.86 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.82 by $0.04. Colgate-Palmolive had a net margin of 13.22% and a return on equity of 485.40%. The company had revenue of $5.07 billion during the quarter, compared to analyst estimates of $4.96 billion. During the same quarter in the prior year, the business earned $0.73 earnings per share. The business's quarterly revenue was up 6.2% compared to the same quarter last year. As a group, equities research analysts anticipate that Colgate-Palmolive will post 3.53 earnings per share for the current year.

Colgate-Palmolive Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, May 15th. Stockholders of record on Monday, April 22nd were given a dividend of $0.50 per share. This is a boost from Colgate-Palmolive's previous quarterly dividend of $0.48. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.12%. The ex-dividend date of this dividend was Friday, April 19th. Colgate-Palmolive's payout ratio is presently 63.29%.

Colgate-Palmolive Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Further Reading

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should you invest $1,000 in Colgate-Palmolive right now?

Before you consider Colgate-Palmolive, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.

While Colgate-Palmolive currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Featured Articles and Offers

7 Must-Buy Stocks Under $20

7 Must-Buy Stocks Under $20

In this video, we highlight seven stocks under $20 that are worth a closer look.

Search Headlines: